STAUDERMAN KENNETH A. (Chief Scientific Officer) purchased 1K shares of CALCIMEDICA, INC. on the open market
Open‑market purchase worth $1.9K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/2/2025ACC: 0001415889-25-019190
Officer· Chief Scientific Officer
Since Mar 2023
+1K
Net shares
Net buyer
$1.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1K
Price / share
$1.85
Trade value
$1.85K
% of position
New position
7/1/2025
0.00→1K
Total
Net shares
+1K
Net value
$1.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/1/2025 | P · Purchase | +1K | $1.85 | $1.85K | New position | 0.00 | 1K |
| Total | +1K | $1.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned11.94K
Total
11.94K direct11.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 11.94K | Direct |
| Total | 11.94K | 11.94K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported